enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. NNC2215 - Wikipedia

    en.wikipedia.org/wiki/NNC2215

    The drug is designed by a team of Novo Nordisk researchers. [1] NNC2215 can sense the glucose concentration presence in blood. The protein's sensitivity is reduced when low concentration of glucose, thus reducing the risk of hypoglycemia. [2] In addition, it can effectively cover the risk of fluctuations of blood sugar levels.

  3. FDA approves new version of diabetes drug Mounjaro for weight ...

    www.aol.com/fda-approves-version-diabetes-drug...

    A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly’s drug ...

  4. FDA approves new version of Eli Lilly’s diabetes drug for ...

    www.aol.com/fda-approves-version-eli-lilly...

    Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections.

  5. Mounjaro leads to far more weight loss than Ozempic, real ...

    www.aol.com/watch-ozempic-another-diabetes-drug...

    Ozempic has become a blockbuster drug thanks to its ability to help people lose weight, but Mounjaro, another Type 2 diabetes treatment, appears to be far more effective for weight loss, a new ...

  6. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]

  8. Exenatide - Wikipedia

    en.wikipedia.org/wiki/Exenatide

    Exenatide augments pancreas response [23] (i.e. increases insulin secretion) in response to eating meals; the result is the release of a higher, more appropriate amount of insulin that helps lower the rise in blood sugar from eating. Once blood sugar levels decrease closer to normal values, the pancreas response to produce insulin is reduced ...

  9. Popular weight loss drug may help people with Type 1 diabetes ...

    www.aol.com/news/popular-weight-loss-drug-may...

    People with Type 1 and Type 2 diabetes both have trouble controlling blood sugar levels. But the causes of the conditions — and how they are treated — are different. Type 1 diabetes is an ...